Pfizer (PFE) Tax Rate (2009 - 2026)

Pfizer (PFE) has reported Tax Rate for 18 consecutive years, with 62.33% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Rate rose 5770.0% year-over-year to 62.33% in Q2 2026; TTM through Jun 2026 was 3.9%, a 543.0% decrease from a year earlier, with the FY2025 full-year figure at 3.54%, down 319.0% from the prior year.
• Tax Rate was 62.33% for Q2 2026 at Pfizer, up from 14.54% in the prior quarter.
• Over five years, Tax Rate peaked at 130.1% in Q2 2024 and troughed at 6.79% in Q1 2025.
• A 5-year average of 19.01% and a median of 9.98% in 2024 frame the typical range for Tax Rate.
• Across the five-year window, Tax Rate soared 13323 bps in 2024 and plunged 12547 bps in 2025, its largest moves.
• Over 5 years, Tax Rate stood at 13.72% in 2022, then surged by 40 bps to 19.25% in 2023, then tumbled by 75 bps to 4.89% in 2024, then slumped by 98 bps to 0.12% in 2025, then surged by 51071 bps to 62.33% in 2026.
• The last three Tax Rate figures came in at 62.33% (Q2 2026), 14.54% (Q1 2026), and 0.12% (Q4 2025), per Business Quant data.